3D bioprinting

Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs

Retrieved on: 
화요일, 4월 4, 2023
Other Manufacturing, Other Science, Technology, General Health, Engineering, Chemicals, Plastics, Manufacturing, Surgery, Other Health, Medical Devices, Health Technology, Machinery, Clinical Trials, Machine Tools, Metalworking & Metallurgy, Biotechnology, Other Technology, Software, Health, Hardware, Science, Electronic Design Automation, Tissue, Partnership, 3D, 3D bioprinting, Printing, Connective tissue, Multimedia, Breast augmentation, Regenerative medicine, Stratasys, Regeneration, Patient, Breast, CLGN, Ecosystem, 3D printing, Medical imaging, Birth control

The first project focuses on the development of an industrial-scale solution for CollPlant's regenerative breast implants program.

Key Points: 
  • The first project focuses on the development of an industrial-scale solution for CollPlant's regenerative breast implants program.
  • View the full release here: https://www.businesswire.com/news/home/20230404005729/en/
    Human size breast implant, printed with Stratasys P3 3D printing technology and CollPlant's bioink.
  • CollPlant is a pioneering regenerative and aesthetics medicine company developing innovative technologies and products based on its plant-based collagen for tissue regeneration and organ manufacturing.
  • “Through this partnership with CollPlant, we have an important opportunity to transform healthcare with bioprinting to improve the lives of patients undergoing breast augmentation or reconstruction procedures,” said Stratasys CEO Dr. Yoav Zeif.

Global 3D Bioprinting Market Report 2022: Sector to Reach $5 Billion by 2028 at a CAGR of 15%

Retrieved on: 
목요일, 3월 23, 2023
Government, Vaccine, Regenerative medicine, Printing, Tissue, 3D bioprinting, Drug discovery, Growth, Component, Research, Biomaterial, 3D printing, Medical imaging, Pharmaceutical industry

By Material: The living cells segment held the largest market share in the global 3D bioprinting market in 2021, owing to rising demand from the pharmaceutical industry.

Key Points: 
  • By Material: The living cells segment held the largest market share in the global 3D bioprinting market in 2021, owing to rising demand from the pharmaceutical industry.
  • Using living cells as bio-inks, the inkjet technology allows for the printing of complex organs and tissues on culture substrates.
  • By Application: The clinical application segment held the largest market share in the global 3D bioprinting market in 2021, owing to utilization of bioprinting technology in clinical trials of various diseases.
  • By Region: North America held the largest market share among all other regions within the global 3D bioprinting market in 2021, due to the supporting government policies to augment the growth of the region.

Global 3D Bioprinting Intellectual Property (IP) Landscape Report 2023: Patent Filing Trends, Prior Art Search Expressions, Patentability, Freedom to Operate, Innovation, White Spaces, Claim Analysis - ResearchAndMarkets.com

Retrieved on: 
금요일, 3월 10, 2023
Health, Biotechnology, History, Literature, 3D bioprinting, Patent, Cartilage, Data, 3D, Stereolithography, Toxicology, Microsoft Excel, Skin, Transplant, D, GDP, Research, Benchmarking, IP, CPC, Pocket, Marketing, Printing, Gross domestic product, Intelligence, Ecosystem, 3D printing, Creative industries

The "3D Bioprinting: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claim Analysis)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "3D Bioprinting: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claim Analysis)" report has been added to ResearchAndMarkets.com's offering.
  • This report captures some of the key R&D-related trends and provides competitive intelligence on the intellectual property in the field of 3D bioprinting.
  • The "3D Bioprinting: Intellectual Property Landscape" report features an extensive study of some of the key historical and contemporary intellectual property (IP) documents (featuring granted patents, patent applications and other documents), describing the various types of 3D bioprinting.
  • Despite the various advantages associated with 3D bioprinting, the technology is associated with certain challenges.

Global 3D Bioprinting Intellectual Property (IP) Landscape Report 2023: Advantages, Key Application Areas and Future Perspective of 3D Bioprinting

Retrieved on: 
목요일, 3월 9, 2023
Transplant, 3D bioprinting, Ecosystem, Gross domestic product, Stereolithography, Research, Data, Patent, Biotechnology, IP, GDP, Intelligence, History, Literature, Toxicology, Benchmarking, Pocket, Microsoft Excel, CPC, Cartilage, Printing, D, 3D, Marketing, Skin, Health, 3D printing, Creative industries

This report captures some of the key R&D-related trends and provides competitive intelligence on the intellectual property in the field of 3D bioprinting.

Key Points: 
  • This report captures some of the key R&D-related trends and provides competitive intelligence on the intellectual property in the field of 3D bioprinting.
  • The "3D Bioprinting: Intellectual Property Landscape" report features an extensive study of some of the key historical and contemporary intellectual property (IP) documents (featuring granted patents, patent applications and other documents), describing the various types of 3D bioprinting.
  • Despite the various advantages associated with 3D bioprinting, the technology is associated with certain challenges.
  • As a result, the intellectual capital related to different 3D bioprinting techniques, such as extrusion bioprinting, inkjet printing, laser assisted bioprinting and stereolithography, has also grown.

Heart Muscle Tissue Chips Among Life Science Investigations Launching to ISS on SpaceX CRS-27

Retrieved on: 
수요일, 3월 8, 2023
Redwire, SpaceX, Boeing, ISS National Lab, Stanford University, BFF, CRS, Meniscus, Research, Bangladesh Technical Education Board, 3D bioprinting, Crystallization, Biotechnology, International Space Station, SPACE, Heart, Tissue, Partnership, Kennedy Space Center Launch Complex 39A, Kennedy Space Center, Patient, Johns Hopkins University, Commercial Resupply Services, Skeletal muscle, ISS, National Center for Advancing Translational Sciences, Medicine, Bristol Myers Squibb, Temperature, Knowledge, Scientific research on the International Space Station, United States Commercial Service, MassChallenge, NIH, National Center for Research Resources, Pharmaceutical industry, Communications satellite, 3D printing, Science

These projects, sponsored by the ISS National Laboratory, will study microgravity's effects on engineered heart muscle tissue, and results could lead to new treatments for heart disease.

Key Points: 
  • These projects, sponsored by the ISS National Laboratory, will study microgravity's effects on engineered heart muscle tissue, and results could lead to new treatments for heart disease.
  • These projects were funded through the Tissue Chips in Space initiative , a multiyear collaboration between the ISS National Lab and NIH's National Center for Advancing Translational Sciences.
  • Muscles, including the heart, can weaken in microgravity, so heart muscle tissue chips in space could be used to model heart disease and screen potential new drugs.
  • These are only a few of the investigations sponsored by the ISS National Lab that are launching on this mission.

3D Systems Announces Regenerative Tissue Program to Deliver Breakthrough Personalized Solutions for Surgical Reconstruction

Retrieved on: 
목요일, 2월 16, 2023
Regenerative medicine, Health, Woman, Blood, World Health Organization, 3D bioprinting, Tissue, Breast cancer, NYSE, Lumpectomy, Lung, Patient, Breast augmentation, Liver, System, Research, 3D Systems, Mastectomy, Family, Biomaterial, Survival rate, Adipose tissue, RBT, Physiology, FDA, Regeneration, ROCK, Surgeon, 3D, VSP, Kidney, Medical imaging

Initial focus on development, commercialization of soft tissue applications enabling disruptive autologous reconstruction solutions, utilizing company’s VSP® surgical planning solutions and experience in patient-specific medical implants

Key Points: 
  • Initial focus on development, commercialization of soft tissue applications enabling disruptive autologous reconstruction solutions, utilizing company’s VSP® surgical planning solutions and experience in patient-specific medical implants
    ROCK HILL, S.C., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE:DDD) introduced its Regenerative Tissue Program intended to provide an unparalleled solution for surgical procedures requiring reconstruction.
  • 3D Systems has established this program as a result of the significant progress achieved in developing next-generation bioprinting solutions for 3D-printed solid organs.
  • “The level of innovation we’ve been able to unlock with our solutions for regenerative medicine is allowing us to deliver an unmatched level of complexity and precision,” said Dr. Jeffrey Graves, president and CEO, 3D Systems.
  • “Through the Regenerative Tissue Program, we now have a unique, vertically integrated technology platform that enables us to produce detailed hydrogel scaffolds for multiple soft tissue applications,” said Katie Weimer, vice president, regenerative medicine, 3D Systems.

Global Induced Pluripotent Stem Cell (iPSC) Industry Report 2023: Profiles Leading Market Competitors, Including FUJIFILM CDI, ReproCELL, Evotec, Ncardia, and Axol Bioscience - ResearchAndMarkets.com

Retrieved on: 
월요일, 2월 13, 2023
Health, Stem Cells, Macular degeneration, Regenerative medicine, Cellular Dynamics International, B cell, Toxicology, Game Industry Report Magazine, Human, Thermo Fisher Scientific, Drug development, Therapy, IPSC, Medicine, Cell, 3D bioprinting, Safety, University of Wisconsin–Madison, Patient, CRISPR, Clinical trial, CLI, University, CDI, Research, MSC, Tissue engineering, Merck, Graft-versus-host disease, Kyoto University, Personalized medicine, Disease, Partnership, OA, COVID-19, Drug discovery, Microsoft Exchange Server, Osteoarthritis, Pharmaceutical industry, Veterinary medicine, Mobile phone, Fine chemical

The "Global Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, and Forecasts, 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, and Forecasts, 2023" report has been added to ResearchAndMarkets.com's offering.
  • Since the discovery of induced pluripotent stem cell (iPSC) technology in 2006, significant progress has been made in stem cell biology and regenerative medicine.
  • Personalized Medicine:The use of techniques such as CRISPR enables precise, directed the creation of knock-outs and knock-ins (including single base changes) in many cell types.
  • Headquartered in Cambridge, UK, it specializes in human cell culture, providing iPSC-derived cells and iPSC-specific cell culture products.

Worldwide 3D Bioprinters Industry to 2030 - Featuring BioBots, TeVido BioDevices, 3D Dynamic Systems and Rokit Among Others - ResearchAndMarkets.com

Retrieved on: 
목요일, 2월 2, 2023
Technology, Biotechnology, Health, Hardware, Food, Intelligence, 3D bioprinting, 3D printing, Speciality chemicals

This report on global 3D Bioprinters Market studies various technologies used for specific applications in the field of healthcare.

Key Points: 
  • This report on global 3D Bioprinters Market studies various technologies used for specific applications in the field of healthcare.
  • bioprinters helps to replicate human organs and long term goal is to create a whole organ with this technology.
  • For the purpose of this study, the various technology segments studied include syringe based 3D bioprinters, laser based 3D bioprinters, magnetic levitation 3D bioprinters, inkjet based 3D bioprinters and valve-based 3D bioprinters.
  • The geographic segmentation of the global 3D bioprinters market is performed for the regions North America, Europe, Asia Pacific and Rest of the World markets.

Swave Photonics, QART Medical, and PhosPrint win big at 2023 SPIE Startup Challenge

Retrieved on: 
수요일, 2월 1, 2023
Hardware, Health Technology, Semiconductor, Electronic Design Automation, Manufacturing, Technology, Nanotechnology, Audio, Video, Biotechnology, Science, Software, Other Science, Research, Health, Mobile, Wireless, Engineering, Edmund Scientific Corporation, 3D bioprinting, SPIE, Food safety, MKS Instruments, Entrepreneurship, IVF, Multimedia, MKS, 3D, AR, Video game, Thorlabs

View the full release here: https://www.businesswire.com/news/home/20230201005834/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230201005834/en/
    Jenoptik’s Ralf Kuschnereit, far left, Swave Co-Founder and Chief Product Officer Theo Marescaux, Swave CEO Mike Noonen, and 2023 SPIE Vice President Peter de Groot.
  • All cash prizes are provided by SPIE Startup Challenge Founding Partner Jenoptik.
  • “Participating at the Startup Challenge was an award in itself, but to actually win first-place recognition, well, our team is very excited.
  • “It was exciting for us to have the opportunity to present our startup at the SPIE Startup Challenge.

Asia Pacific Artificial Organs and Bionics Markets, Competition, Forecast & Opportunities, 2028 - ResearchAndMarkets.com

Retrieved on: 
금요일, 1월 27, 2023
Cardiology, Biotechnology, Managed Care, Other Health, Diabetes, Health, General Health, Health Technology, Medical Devices, Hospitals, Surgery, Forecast, Disability, Accident, Artificiality, Bionics, Pelvic floor dysfunction, Organic, Country, 3D bioprinting, Competition, Artificial organ, Artificial intelligence, Kidney, Amputation, Growth, Conditional sentence, Environment, Video game, Retail, Agriculture, Tissue paper, Others

Asia Pacific artificial organs and bionics market is expected to grow at a significant rate during the forecast period, 2024-2028.

Key Points: 
  • Asia Pacific artificial organs and bionics market is expected to grow at a significant rate during the forecast period, 2024-2028.
  • To analyze and forecast the market size of Asia Pacific artificial organs and bionics market.
  • To classify and forecast Asia Pacific artificial organs and bionics market based on product, technology, material, end-user, company and country.
  • Company Profiles: Detailed analysis of the major companies present in Asia Pacific artificial organs and bionics market.